ARCHIVES

FDA Approves Folotyn For Peripheral T-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

NCAB Votes Down Effort to Delay CCOP RFA, Directs Subcommittee To Look Again A Program Components

February 12, 1982

Low Dose DFMO Reduces Colon Adenoma Recurrence

April 25, 2008

ODAC Finds Increase In Progression-Free Survival Unconvincing To Approve sNDA For Gemzar In Advanced Ovarian Cancer.

March 24, 2006

NCI Cooperative Group, Cancer Center Trials Listed

October 31, 2008

FDA Approves Molecular Test For Breast Cancer Detection

July 27, 2007

Conversation with The Cancer Letter: Daniel Hayes Leads Tour of Caris Website

August 8, 2014